1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one
C31H32N6O2 — CID 159450606
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one
1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one (PubChem CID 159450606) has the molecular formula C31H32N6O2 and a molecular weight of 520.64 g/mol. Its IUPAC name is 1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one.
Molecular Properties
| Compound Name | 1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one |
|---|---|
| PubChem CID | 159450606 |
| Molecular Formula | C31H32N6O2 |
| Molecular Weight | 520.64 g/mol |
| Exact Mass | 520.26 |
| IUPAC Name | 1-[6-[3-[6-(2-oxo-3-pyridin-2-ylpropyl)pyridazin-3-yl]cycloheptyl]pyridazin-3-yl]-3-pyridin-2-ylpropan-2-one |
| SMILES | O=C(Cc1ccccn1)Cc1ccc(C2CCCCC(c3ccc(CC(=O)Cc4ccccn4)nn3)C2)nn1 |
| InChI | InChI=1S/C31H32N6O2/c38-28(18-24-9-3-5-15-32-24)20-26-11-13-30(36-34-26)22-7-1-2-8-23(17-22)31-14-12-27(35-37-31)21-29(39)19-25-10-4-6-16-33-25/h3-6,9-16,22-23H,1-2,7-8,17-21H2 |
| InChIKey | LTIAXIGHYNVQKY-UHFFFAOYSA-N |
| XLogP | 4.60 |
| TPSA | 111.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.64 |
| LogP ≤ 5 | 4.60 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159450606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.